Perspective Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CATX and other ETFs, options, and stocks.About CATX
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
CEOJohan M. Spoor
CEOJohan M. Spoor
Employees140
Employees140
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded1983
Founded1983
Employees140
Employees140
CATX Key Statistics
Market cap212.23M
Market cap212.23M
Price-Earnings ratio-1.95
Price-Earnings ratio-1.95
Dividend yield—
Dividend yield—
Average volume1.07M
Average volume1.07M
High today$2.95
High today$2.95
Low today$2.66
Low today$2.66
Open price$2.80
Open price$2.80
Volume1.88M
Volume1.88M
52 Week high$5.39
52 Week high$5.39
52 Week low$1.60
52 Week low$1.60
Stock Snapshot
Perspective Therapeutics(CATX) stock is priced at $2.87, giving the company a market capitalization of 212.23M. It carries a P/E multiple of -1.95.
On 2026-01-11, Perspective Therapeutics(CATX) stock moved within a range of $2.66 to $2.95. With shares now at $2.87, the stock is trading +7.9% above its intraday low and -2.7% below the session's peak.
Trading volume for Perspective Therapeutics(CATX) stock has reached 1.88M, versus its average volume of 1.07M.
The stock's 52-week range extends from a low of $1.60 to a high of $5.39.
The stock's 52-week range extends from a low of $1.60 to a high of $5.39.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own CATX. This list is generated using Robinhood data, and it’s not a recommendation.